SCHEMBL3667342

SCHEMBL3667342

O=C(O)N1CCC(n2c(=O)n(S(=O)(=O)c3ccc(F)cc3)c3ccccc32)C[C@@H]1CCCN(Cc1ccccc1)Cc1ccccc1.O=c1[nH]c2ccccc2[nH]1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM1 P11229 6/20 0.34
▸ DRD2 P14416 4/20 0.34
▸ HTR1A P08908 3/20 0.34
▸ HTR2A P28223 3/20 0.34
▸ DRD3 P35462 3/20 0.34
▸ KCNH2 Q12809 3/20 0.34
▸ MLNR O43193 2/20 0.34
▸ LMNA P02545 2/20 0.34
▸ PGR P06401 2/20 0.34
▸ ADRB2 P07550 2/20 0.34
▸ CHRM2 P08172 2/20 0.34
▸ ADRB1 P08588 2/20 0.34
▸ ADRA2A P08913 2/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ ADRA2B P18089 2/20 0.34
▸ ADRA2C P18825 2/20 0.34
▸ DRD1 P21728 2/20 0.34
▸ DRD4 P21917 2/20 0.34
▸ SLC6A2 P23975 2/20 0.34
▸ HTR2C P28335 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3665443 0.94 RXFP1 (0.36) RXFP1KDM4ECACNA1GCACNA1HALDH1A1
SCHEMBL3808537 0.90 CACNA1G (0.34) CHRM1DRD2CYP2D6RXFP1CACNA1G
SCHEMBL3665336 0.89 CHRM5 (0.36) CACNA1GCACNA1HTSHRAVPR1ANPSR1
SCHEMBL3668869 0.89 BCHE (0.33) OPRK1KDM4ECACNA1GCACNA1HALDH1A1
SCHEMBL3671643 0.86 CHRM5 (0.39) LMNACHRM2CYP2D6KDM4EALDH1A1
SCHEMBL4735430 0.86 CACNA1G (0.35) LMNARXFP1KDM4ECACNA1GCACNA1H
SCHEMBL4800257 0.84 OPRL1 (0.36) HTR2ACYP2D6HTR2COPRK1CACNA1G
SCHEMBL3665332 0.82 POLB (0.35) OPRK1CACNA1GCACNA1HALDH1A1AGTR1
SCHEMBL1838176 0.81 OPRK1 (0.50) CHRM1DRD2HTR1AHTR2ADRD3
SCHEMBL1836260 0.81 OPRK1 (0.50) CHRM1DRD2HTR1AHTR2ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback